27.36 USD
-0.33 (-1.19%)
27.24 USD
-0.12 (-0.44%)
ChartMill assigns a Buy % Consensus number of 78% to AMPH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 33.05. This target is 20.79% above the current price.
AMPH was analyzed by 12 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about AMPH.
In the previous month the buy percentage consensus was at a similar level.
AMPH was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-07 | Needham | Maintains | Buy -> Buy |
| 2025-10-22 | Needham | Reiterate | Buy -> Buy |
| 2025-08-26 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-08-12 | Needham | Upgrade | Hold -> Buy |
| 2025-08-08 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-05-12 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-05-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-10 | Needham | Reiterate | Hold -> Hold |
| 2025-03-21 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-02-04 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2024-11-22 | Wells Fargo | Initiate | Overweight |
| 2024-08-08 | Needham | Reiterate | Hold |
| 2024-08-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-06-27 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-05-22 | Needham | Reiterate | Hold |
| 2024-05-09 | Needham | Reiterate | Hold |
| 2024-04-10 | Needham | Reiterate | Hold |
| 2024-03-05 | JP Morgan | Initiate | Overweight |
| 2023-11-17 | B of A Securities | Initiate | Neutral |
| 2023-07-25 | Jefferies | Reiterate | Buy -> Buy |
| 2023-05-17 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2022-10-25 | Piper Sandler | Maintains | Overweight |
| 2022-07-29 | Capital One | Initiate | Overweight |
| 2022-03-11 | Piper Sandler | Maintains | Overweight |
| 2022-01-07 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2021-03-17 | Wells Fargo | Maintains | Equal-Weight |
AMPHASTAR PHARMACEUTICALS IN / AMPH FAQ
Can you provide the average price target for AMPHASTAR PHARMACEUTICALS IN stock?
12 analysts have analysed AMPH and the average price target is 33.05 USD. This implies a price increase of 20.79% is expected in the next year compared to the current price of 27.36.
How do analysts rate AMPHASTAR PHARMACEUTICALS IN (AMPH)?
The consensus rating for AMPHASTAR PHARMACEUTICALS IN (AMPH) is 78.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for AMPHASTAR PHARMACEUTICALS IN stock?
The number of analysts covering AMPHASTAR PHARMACEUTICALS IN (AMPH) is 12.